Modeling and Analysis of COVID-19 Spread: The Impacts of Nonpharmaceutical Protocols

<div>Effect of transmission rate (<span class="nowrap"><svg height="9.14241pt" id="M301" style="vertical-align:-3.1815pt" version="1.1" viewbox="-0.0498162 -5.96091 10.0698 9.14241" width="10.0698pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M387 375C387 402 357 448 257 448C172 448 82 404 82 326C82 289 108 255 156 241V239C85 223 23 181 23 116C23 39 89 -12 182 -12C265 -12 336 31 378 91L361 114C320 73 269 47 216 47C157 47 115 82 115 137C115 191 160 219 218 219C243 219 262 218 272 217L304 259L302 266C295 265 281 264 255 264C195 264 163 294 163 335C163 377 200 416 249 416C293 416 321 389 329 342C331 332 335 329 341 329C355 329 387 352 387 375Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,5.005,3.132)"><path d="M389 0V32C297 38 291 46 291 118V635C234 613 175 595 109 583V556L161 554C203 552 207 547 207 497V118C207 46 201 38 110 32V0H389Z"></path></g></svg>)</span> from asymptomatic individuals on the variation of confirmed COVID-19 cases in Egypt.</div>

Computational and Mathematical Methods in Medicine

fig6

Figure 6

Figure 6: Modeling and Analysis of COVID-19 Spread: The Impacts of Nonpharmaceutical Protocols 